The federal government is rolling out a new program that will enable some Medicare recipients to access GLP-1 weight loss ...
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...
The program is designed to expand access to a high-demand class of medications that have been financially out of reach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results